140 related articles for article (PubMed ID: 35421932)
1. Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
He Y; Han SB; Liu Y; Zhang JJ; Wu YM
BMC Cancer; 2022 Apr; 22(1):411. PubMed ID: 35421932
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ.
He Y; Han SB; Geng YN; Yang SL; Wu YM
J Gynecol Oncol; 2020 May; 31(3):e28. PubMed ID: 31912682
[TBL] [Abstract][Full Text] [Related]
3. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
Wen X; Liu S; Cui M
Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.
Guo L; Wu H; Zhu J; Zhang C; Ma J; Lan J; Xie X
Life Sci; 2015 Dec; 143():217-24. PubMed ID: 26585822
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
6. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
7. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
Duan W; Liu X
Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
[TBL] [Abstract][Full Text] [Related]
8. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
9. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract][Full Text] [Related]
11. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
[TBL] [Abstract][Full Text] [Related]
12. Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.
Takekuma M; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
J Gynecol Oncol; 2015 Jul; 26(3):185-92. PubMed ID: 26197856
[TBL] [Abstract][Full Text] [Related]
13. Effect of GREM 1 gene on chemoradiotherapy sensitivity of cervical squamous carcinoma cells.
Miao H; Song WB; Zhu H; Wang Q; Tian Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1072-1080. PubMed ID: 32096207
[TBL] [Abstract][Full Text] [Related]
14. Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway.
Zhang J; Zhang Y; Liu S; Zhang Q; Wang Y; Tong L; Chen X; Ji Y; Shang Q; Xu B; Chu M; Wei L
Tumour Biol; 2013 Aug; 34(4):2433-40. PubMed ID: 23595222
[TBL] [Abstract][Full Text] [Related]
15. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
Shu XR; Wu J; Sun H; Chi LQ; Wang JH
Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
Chung HH; Kim MK; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2006 Dec; 103(3):1031-7. PubMed ID: 16875718
[TBL] [Abstract][Full Text] [Related]
17. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
Nagai N; Murakami T; Ohama K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1975-9. PubMed ID: 8085848
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
